Recombinant Human C4 binding protein/C4BPB (His tag N-Terminus)
4
(1 Review)
|
(1 Publication)
Recombinant Human C4 binding protein/C4BPB (His tag N-Terminus) is a Human Full Length protein, in the 18 to 252 aa range, expressed in Escherichia coli, with >90%, suitable for SDS-PAGE, Mass Spec.
View Alternative Names
C4b-binding protein beta chain, C4BPB
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human C4 binding protein/C4BPB (His tag N-Terminus) (AB130028)
Reactivity data
Product details
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
C4 binding protein plays a defensive role in the immune system by regulating complement activation. It is part of a larger complex that controls the complement pathway which is integral to immune surveillance and removing pathogens. C4BPB functions primarily by binding to complement C4 preventing the formation of the C3 convertase which is an enzyme that amplifies the complement response. This binding action helps in stabilizing the protein C4 and complement C4 serum to avoid unnecessary immune reactions.
Pathways
The complement system pathway prominently features C4 binding protein. In the classical complement activation pathway C4BPB works closely with other proteins such as C3 and C4 to ensure regulatory balance. Its inhibitory action on the complement C4 pathway provides a safeguard against damage to host tissues during immune responses. The interplay between C4BPB and protein C4 offers a protective mechanism reducing excessive inflammation which can lead to tissue injury.
Specifications
Form
Liquid
Additional notes
ab130028 was purified using conventional chromatography techniques.
General info
Function
Controls the classical pathway of complement activation. It binds as a cofactor to C3b/C4b inactivator (C3bINA), which then hydrolyzes the complement fragment C4b. It also accelerates the degradation of the C4bC2a complex (C3 convertase) by dissociating the complement fragment C2a. It also interacts with anticoagulant protein S and with serum amyloid P component. The beta chain binds protein S.
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 12:4858 PubMed34381048
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com